Risk of Leukaemia After Chemotherapy in Moscow
Author Information
Author(s): D.G. Zaridzel, M.A. Arkadieva, N.E. Day, S.W. Duffy
Primary Institution: Department of Epidemiology, Cancer Research Center RAMS
Hypothesis
Does chemotherapy for first primary tumors increase the risk of acute non-lymphocytic leukaemia (ANLL)?
Conclusion
The study suggests that certain non-alkylating chemotherapeutic agents may increase the risk of developing second malignancies, particularly ANLL.
Supporting Evidence
- Chemotherapy with nitrogen mustard, doxorubicin, and vincristine was associated with increased risks of ANLL.
- The odds ratio for vincristine use was 26.57, indicating a significant risk.
- Previous studies have shown that alkylating agents increase the risk of leukaemia.
Takeaway
This study looked at people who had cancer treatment and found that some medicines might make it more likely for them to get another type of cancer called leukaemia.
Methodology
A case-control study was conducted with 165 cases of ANLL and 294 matched controls, assessing the risk associated with various chemotherapeutic agents.
Potential Biases
There is a risk of selection bias due to the matching of cases and controls based on relapse history.
Limitations
The small number of cases and potential confounding by other agents limit the findings.
Participant Demographics
The study included 20 male cases and 145 female cases, with a total of 165 cases and 294 controls.
Statistical Information
P-Value
0.1 > P > 0.05
Confidence Interval
(1.25, 5.60)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website